What is the most common route of hepatitis C acquisition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Route of Hepatitis C Acquisition

Injection drug use is currently the most common route of hepatitis C transmission in developed countries, accounting for 60-68% of newly acquired infections in the United States. 1, 2

Current Transmission Landscape

Injection Drug Use: The Dominant Route

  • Injection drug use accounts for the majority of ongoing HCV transmission in the United States and other developed nations, with prevalence rates of 50-90% among people who inject drugs. 1, 2

  • HCV is acquired more rapidly after initiating injection drug use compared to other bloodborne viruses (HIV, HBV), with up to 90% of users infected within 5 years of starting injection. 1

  • Transmission occurs through sharing syringes and needles either directly or through contamination of drug preparation equipment, making even limited or occasional drug injection a significant risk factor. 1

  • Many persons with chronic HCV infection acquired their infection 20-30 years ago from limited or occasional illegal drug injecting, even if they do not currently consider themselves drug users. 1

Historical vs. Current Routes

  • Blood transfusion and organ transplantation were major transmission routes until 1991, but universal donor screening has reduced the risk to approximately 0.001% per unit transfused. 1, 2

  • Clotting factor concentrates caused infection rates up to 90% in hemophiliacs before viral inactivation procedures were introduced in 1985-1987, but this route has been virtually eliminated. 1

  • The dramatic decline in acute hepatitis C incidence since 1989 correlates with decreased cases among injection drug users, though the reasons for this decline remain unclear. 1

Geographic and Regional Variations

Developed Countries

  • In the United States and Europe, injection drug use is the predominant route, with other routes playing minimal roles in new infections. 1, 2

Developing Countries

  • Unsafe injection practices with multiple-use medication vials, reused syringes, and unsanitary medical procedures (surgery, endoscopy, dental treatment) are the main causes of HCV transmission in developing countries. 1, 2

  • Nosocomial transmission through inadequate infection control and contaminated equipment sharing remains a significant problem in resource-limited settings. 1

Other Transmission Routes (Lower Risk)

Healthcare-Associated Transmission

  • Hemodialysis patients show average anti-HCV prevalence of 10%, with some centers reporting rates exceeding 60%, primarily due to inadequate infection control practices. 1, 2

  • Occupational needlestick injuries carry a transmission risk of 1.8% (range 0-7%) in most countries and 0.92% in South Korea, but healthcare workers overall have no higher prevalence than the general population. 1, 2

Sexual Transmission

  • Long-term monogamous heterosexual relationships show very low transmission risk, with average HCV prevalence of only 1.5% among steady spouses. 1, 2

  • Multiple sexual partners, high-risk sexual practices (anal sex, sex with wounds), concurrent sexually transmitted diseases (especially HIV), and male-to-male sexual contact increase transmission risk. 1, 2

Perinatal Transmission

  • Vertical transmission occurs in 4.3% (range 3.9-7.1%) of infants born to HCV RNA-positive mothers, with rates increasing to 14-17% when mothers are HIV-coinfected. 1, 2

  • Breastfeeding is not a route of transmission and is not contraindicated unless nipples are cracked or bleeding. 1, 2

Other Percutaneous Exposures

  • Tattooing, piercing, and acupuncture without proper disinfection are documented risk factors, though the absolute risk is likely low if performed in licensed establishments. 1, 2

  • Intranasal cocaine use has been independently associated with HCV infection, possibly through sharing contaminated straws, though this rarely contributes to transmission in the absence of injection drug use. 1

Clinical Implications

Who to Test

  • All adults aged ≥18 years should receive hepatitis C screening at least once in a lifetime, except in settings where HCV prevalence is <0.1%. 3

  • All pregnant women should be screened during each pregnancy, except in settings where HCV prevalence is <0.1%. 3

  • Persons with ongoing risk factors (injection drug use, hemodialysis, HIV infection, multiple sexual partners) should receive periodic testing while risk factors persist. 1, 3

Prevention Counseling

  • HCV-infected persons should be counseled to avoid donating blood, organs, tissues, or semen, and not to share any instruments that penetrate skin (toothbrushes, razors, nail clippers). 1, 2

  • For monogamous couples, barrier protection is not necessarily recommended given the very low transmission risk, but latex condoms should be used for those with multiple partners or high-risk sexual practices. 2

  • Primary prevention of illegal drug injection will eliminate the greatest risk factor for HCV infection, with risk reduction counseling and services being critical. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis C Virus Transmission and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2020

Research

Prevention of spread of hepatitis C.

Hepatology (Baltimore, Md.), 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.